Human papillomavirus infection and its role in the genesis of dysplastic and neoplastic lesions of the squamous epithelia

New Microbiologica

Volumn 28, Issue 2, 2005, Pages 111-118

  Lillo, Flavia B ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Cervical carcinoma; HPV; Oncogenic process; Prevention

Indexed keywords

ANUS TUMOR; BOWENOID PAPULOSIS; CANCER INCIDENCE; CARCINOGENICITY; CLINICAL FEATURE; CONDYLOMA; CONDYLOMA ACUMINATUM; HUMAN; LIFE CYCLE; PHYLOGENY; REVIEW; SCREENING; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VACCINATION; VAGINA TUMOR; VIRUS INFECTION; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 21244444995     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. AOKI, Y., AND TOSATO, G. (2004). Neoplastic conditions in the context of HIV-1 infection. Curr HIV Res, 2, 343-349.
2. APPLE, R.J., ERLICH, H.A., KLITZ, W., MANOS, M.M., BECKER, T.M., AND WHEELER, C.M. (1994). HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet, 6, 157-162.
3. BOUSARGHIN, L., TOUZE, A., COMBITA-ROJAS, A.L., AND COURSAGET, P. (2003). Positively charged sequences of human papillomavirus type 16 capsid proteins are sufficient to mediate gene transfer into target cells via the heparan sulfate receptor. J Gen Virol, 84, 157-164.
4. BRADY, C.S., DUGGAN-KEEN, M.F., DAVIDSON, J.A., J.M. VARLEY, , AND P. L. STERN. (1999). Human papillomavirus type 16 E6 variants in cervical carcinoma: relationship to host genetic factors and clinical parameters. J Gen Virol, 80 (Pt 12): 3233-3240.
5. CASTELLSAGUE, X., BOSCH, F.X. AND MUNOZ, N. (2002). Environmental co-factors in HPV carcinogenesis. Virus Res, 89, 191-199.
6. CHAN, S.Y., DELIUS, H., HALPERN, A.L., AND BERNARD, H.U. (1995). Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol, 69, 3074-83.
7. CHIANG, C.M., USTAV, M., STENLUND, A., Ho, T.F., BROKER, T.R., AND CHOW, L.T. (1992). Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc Natl Acad Sci USA, 89, 5799-5803.
8. DONG, X.P., STUBENRAUCH, F., BEYER-FINKLER, E., AND PFISTER, H. (1994). Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int J Cancer 58: 803-808.
9. FRAZER, I.H. (2004). Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol, 4, 46-54.
10. GIANNOUDIS, A., AND HERRINGTON, C.S. (2001). Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol, 193, 295-302.
11. GIROGLOU, T., FLORIN, L., SCHAFER, F., STREECK, R.E., AND SAPP, M. (2001). Human papillomavirus infection requires cell surface heparan sulfate. J Virol, 75, 1565-1570.
12. HANAHAN, D., AND WEINBERG R.A. (2000). The hallmarks of cancer. Cell, 100, 57-70.
13. HAWLEY-NELSON, P., VOUSDEN, K.H., HUBBERT, N.L., LOWY D.R., AND SCHILLER J.T. (1989). HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. Embo J, 8, 3905-3910.
14. HILDESHEIM, A., HERRERO R., CASTLE P.E., WACHOLDER, S., BRATTI M.C., SHERMAN M.E., LORINCZ A.T., BURK R.D., MORALES J., RODRIGUEZ A.C., HELGESEN, K., ALFARO, M., HUTCHINSON, M., BALMACEDA, I., GREENBERG, M., AND SCHIFFMAN, M. (2001). HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J, Cancer, 84, 1219-1226.
15. HO, L., CHAN, S.Y., BURK, R.D., DAS, B.C., FUJINAGA, K., ICENOGLE, J.P., KAHN, KIVIAT, T.N., LANCASTER, W., MAVROMARA-NAZOS, P., AND ET AL. (1993). The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol, 67, 6413-6423.
16. HOLMES, E.C. (2004). The phylogeography of human viruses. Mol Ecol, 13, 745-756.
17. IARC. 2001. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. IARCPress IARC CancerBase.
18. JAMISON, J.H., KAPLAN, D.W., HAMMAN, R., EAGAR, R., BEACH, R., AND DOUGLAS, I.M., JR. (1995). Spectrum of genital human papillomavirus infection in a female adolescent population. Sex Transm Dis, 23, 236-243.
19. JANSEN, K.U. (2004). Toward vaccines against cervical cancer. Curr Opin Drug Discov Devel, 7, 228-232.
20. JEON, S., AND LAMBERT, P.F. 1995. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci USA, 92, 1654-1658.
21. JORDAN, L.B., AND MONAGHAN, H. (2004). Pathology of the cervix: recent developments. Clin Oncol (R Coll Radiol), 16, 248-254.
22. KAHN, J.A., ROSENTHAL, S.L., SUCCOP, P.A., HO, G.Y., AND BURK, R.D. (2002). The interval between menarche and age of first sexual intercourse as a risk factor for subsequent HPV infection in adolescent and young adult women. J Pediatr, 141, 718-723.
23. KOUTSKY, L. (1997). Epidemiology of genital human papillomavirus infection. Am J Med, 102, 3-8.
24. LILLO, F.B., FERRARI, D., VEGLIA, F., ORIGONI, M., GRASSO, M.A., LODINI, S., MASTRORILLI, E., TACCAGNI, G., LAZZARIN, A., AND UBERTI-FOPPA, C. (2001). Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis, 184, 547-551.
25. MARSHALL, S.E., BORDEA, C., WOJNAROWSKA, F., MORRIS, P.J., AND WELSH, K.I. (2000). p53 codon 72 polymorphism and susceptibility to skin cancer after renal transplantation. Transplantation, 69, 994-946.
26. MCMILLAN, N.A., PAYNE, E., FRAZER, I.H., AND EVANDER, M. (1999). Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells. Virology, 261, 271-279.
27. MONSONEGO, J., BOSCH, F.X., COURSAGET, P., COX, J.T., FRANCO, E., FRAZER, I., SANKARANARAYANAN, R., SCHILLER, J., SINGER, A., WRIGHT, T.C. JR., KINNEY, W., MEIJER, C.J., J. LINDER, MCGOOGAN, E., AND MEIJER, C. 2004. Cervical cancer control, priorities and new directions. Int J Cancer, 108, 329-333.
28. MUNGER, K., WERNESS, B.A., DYSON, N., PHELPS, W.C., HARLOW, E., AND HOWLEY, P.M. (1989). Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. Embo J, 8, 4099-4105.
29. MUNOZ, N., BOSCH, F.X., CASTELLSAGUE, X., DIAZ, M., DE SANJOSE, S., HAMMOUDA, D., SHAH, K.V., AND MEIJER, C.J. (2004). Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer, 111, 278-285.
30. ORDONEZ, R.M., ESPINOSA, A.M., SANCHEZ-GONZALEZ, D.J., ARMENDARIZ-BORUNDA, J., AND BERUMEN, J. (2004). Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription. J Gen Virol, 85, 1433-1444.
31. RAJEEVAN, M.S., SWAN, D.C., NISENBAUM, R., LEE, D.R., VERNON, S.D., RUFFIN, M.T., HOROWITZ, I.R., FLOWERS, L.C., KMAK, D., TADROS, T., BIRDSONG, G., HUSAIN, M., SRIVASTAVA, S., AND UNGER, E.R. (2005). Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer.
32. ROHAN, T.E., BURK, R.D., AND FRANCO, E.L. (2003). Toward a reduction of the global burden of cervical cancer. Am J Obstet Gynecol, 189, S37-39.
33. SKIADOPOULOS, M.H., AND MCBRIDE, A.A. (1998). Bovine papillomavirus type 1 genomes and the E2 transactivator protein are closely associated with mitotic chromatin. J Virol, 72, 2079-2088.
34. STEWART, A.C., ERIKSSON, A.M., MANOS, M.M, MUNOZ, N., BOSCH, F.X., PETO, J., AND WHEELER, C.M. (1996). Intratype variation in 12 human papillomavirus types: a worldwide perspective. J Virol, 70, 3127-3136.
35. THIERRY, F., AND YANIV, M trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. Embo J, 6, 3391-3397.
36. UBERTI-FOPPA, C., ORIGONI, M., MAILLARD, M., FERRARI, D., CIUFFREDA, D., MASTRORILLI, E., LAZZARIN, A., AND LIL, F. (1998). Evaluation of the detection of human papillomavirus genotypes in cervical specimens bybrid capture as screening for precancerous lesions in HIV-positive Women. J Med Virol, 56, 133-137.
37. VAN DUIN, M.,SNIJDERS, J., VOSSEN, M.T., KLAASEN, E., VOORHORST, F., VERHEIJEN, R.H., HELMERHORST, T.J., MEIJER, C.J., AND WALBOOMERS, J.M. (2000). Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypcinogenesis. J Gen Virol, 81, 317-325.
38. VILLA, L.L., SICHERO, L., RAHAL, P., CABALLERO, O., FERENCZY, A., ROHAN, T., AND FRANCO, E.L. (2000). Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol, 81, 2959-2968.
39. WANG, S.S., AND HILDESHEIM, A. (2003). Chapter 5: Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr, 35-40.
40. WHEELER, C.M., YAMADA, T., HILDESHEIM, A., AND JENISON, S.A. (1997). Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol, 35, 11-19.
41. YANG, R., DAY, P.M., YUTZY, W.H.T., LIN, H.Y., HUNG, C.F., AND RODEN, R.B. (2003). Cell surface-binding motifs of L2 that facilitate papillomavirus infection. J Virol, 77, 3531-3541.
42. YOON, C.S., KIM, K.D., PARK, S.N., AND CHEONG, S.W. (2001). alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP. Biochem Biophys Res Commun, 283, 668-673.
43. ZEHBE, I., VOGLINO, G., WILANDER, E., GENTA, F, AND TOMMASINO, M. (1999). Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet, 354, 218-219.